Process Development of
Citalopram/Escitalopram Oxalate:
Isolation and Synthesis of Novel Impurities
Posted on 2012-05-18 - 00:00
During process optimization of Escitalopram oxalate novel
impurities, 6 and 7 were observed, which
were isolated and
characterized, and the proposed structure was confirmed by chemical
synthesis. Investigation of the cause of impurities formation improved
the yield and purity of the drug product during the bulk API synthesis.
CITE THIS COLLECTION
DataCite
No result found
Pramanik, Chinmoy; Hivarekar, Raghvendra R.; Deshmukh, Sanjay S.; Tripathy, Narendra
K.; Kotharkar, Sandeep; Chaudhari, Ashok; et al. (2016). Process Development of
Citalopram/Escitalopram Oxalate:
Isolation and Synthesis of Novel Impurities. ACS Publications. Collection. https://doi.org/10.1021/op300039c
or
Select your citation style and then place your mouse over the citation text to select it.
SHARE
Usage metrics
Read the peer-reviewed publication
AUTHORS (7)
- CPChinmoy PramanikRHRaghvendra R. HivarekarSDSanjay S. DeshmukhNTNarendra K. TripathySKSandeep KotharkarACAshok ChaudhariMGMukund K. Gurjar
